Laboratory Testing for Excessive Daytime Sleepiness

Essential Laboratory Tests

The American Geriatrics Society recommends ordering thyroid stimulating hormone (TSH), complete blood count (CBC), comprehensive metabolic panel (CMP) including liver function tests, and ferritin levels as initial laboratory screening for patients with excessive daytime sleepiness 1
Thyroid function (TSH) testing is necessary to exclude hypothyroidism, a treatable metabolic cause of hypersomnia 1
Complete blood count (CBC) is used to identify anemia and other hematologic conditions contributing to fatigue and sleepiness 1
Comprehensive metabolic panel/serum chemistry detects metabolic derangements, renal dysfunction, and electrolyte abnormalities 1
Liver function tests are performed to identify hepatic encephalopathy, which can present as hypersomnia 1
Ferritin level is critical when restless legs syndrome is suspected, with levels <45-50 ng/mL indicating treatable RLS 3

The American Academy of Sleep Medicine recommends polysomnography (PSG) followed by Multiple Sleep Latency Test (MSLT) when central disorders of hypersomnolence (narcolepsy, idiopathic hypersomnia) are suspected after excluding other causes 1
MSLT measures sleep latency across 4-5 daytime naps, with mean sleep latency ≤8 minutes and ≥2 sleep-onset REM periods confirming narcolepsy 1
PSG is the gold standard for diagnosing obstructive sleep apnea in patients with snoring, witnessed apneas, or obesity (BMI ≥33 kg/m²) 4

A thorough medication review should be conducted before ordering extensive testing, as sedating medications are common causes of hypersomnia, particularly in older adults taking multiple medications 2
Patients with BMI ≥40 kg/m² or BMI ≥33 kg/m² plus resistant hypertension or type 2 diabetes warrant comprehensive sleep evaluation for obstructive sleep apnea 4
The presence of cataplexy, hypnagogic hallucinations, or sleep paralysis alongside sleepiness strongly suggests narcolepsy and necessitates PSG/MSLT 1
Brain MRI should be obtained to identify structural causes of hypersomnia, including tumors, multiple sclerosis, strokes, intracranial hemorrhage, or neurodegenerative diseases 1
CSF hypocretin-1 levels can definitively confirm narcolepsy type 1 (with cataplexy) when levels are ≤110 pg/mL, even without MSLT 1